,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', 'astrazeneca', 'astrazenecaus']
 enhertu reduced the risk of disease progression or death by 50% vs. #chemotherapy #asco22 we can extend the time until the #cancer comes back &amp; extend survival such brilliant news from for #breastcancer patients 
Conkers3 works with the #investing/corporate world to promote their insights via bespoke interviews/#podcasts/events. Peter is a #Charity Ambassador @MenphysUK